RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN®  FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

Authors: Khabirov F.A.¹^,2, Khaibullin T.I.¹^,2, Granatov E.V.², Babicheva N.N.², Aver’yanova L.A.², Shakirzyanova S.R.²
Affiliations:
1. Kazan State Medical Academy
2. Republican Clinical Diagnostic Center for demyelinating diseases
Issue: Vol 6, No 4 (2016)
Pages: 28-36
Section: ORIGINAL REPORTS
Published: 04.01.2017
URL: https://nmb.abvpress.ru/jour/article/view/177
DOI: https://doi.org/10.17650/2222-8721-2016-6-4-28-36
ID: 177

Cite item

Full Text

Axoglatiran® FS, Copaxone®-Teva, multiple sclerosis, efficiency, tolerability, safety

Kazan State Medical Academy; Republican Clinical Diagnostic Center for demyelinating diseases

Author for correspondence.
Email: faritkhabirov@yandex.ru

11 Mushtari St., Kazan 420012; 13 Vatutina St., Kazan, Republic of Tatarstan, 420021

Russian Federation

Kazan State Medical Academy; Republican Clinical Diagnostic Center for demyelinating diseases

11 Mushtari St., Kazan 420012; 13 Vatutina St., Kazan, Republic of Tatarstan, 420021

Russian Federation

Republican Clinical Diagnostic Center for demyelinating diseases

13 Vatutina St., Kazan, Republic of Tatarstan, 420021

Russian Federation

Republican Clinical Diagnostic Center for demyelinating diseases

13 Vatutina St., Kazan, Republic of Tatarstan, 420021

Russian Federation

Republican Clinical Diagnostic Center for demyelinating diseases

13 Vatutina St., Kazan, Republic of Tatarstan, 420021

Russian Federation

Republican Clinical Diagnostic Center for demyelinating diseases

Email: fake@neicon.ru
13 Vatutina St., Kazan, Republic of Tatarstan, 420021 Russian Federation

Supplementary Files

Action

1. JATS XML